{"id":"NCT01660763","sponsor":"Talphera, Inc","briefTitle":"Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery","officialTitle":"P3 - A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Knee or Hip Replacement Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2013-04","completion":"2013-05","firstPosted":"2012-08-09","resultsPosted":"2014-02-03","lastUpdate":"2015-10-20"},"enrollment":419,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Post Operative Pain"],"interventions":[{"type":"DRUG","name":"Sufentanil NanoTab PCA System/15 mcg","otherNames":["sufentanil sublingual microtablet system","Zalviso™"]},{"type":"DRUG","name":"Placebo Sufentanil NanoTab PCA System","otherNames":[]}],"arms":[{"label":"Sufentanil NanoTab PCA System/15 mcg","type":"EXPERIMENTAL"},{"label":"Placebo Sufentanil NanoTab PCA System","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to compare the efficacy and safety of the Sufentanil NanoTab PCA System/15 mcg to the Placebo Sufentanil NanoTab PCA System for the management of acute moderate to severe post-operative pain after total unilateral knee or total unilateral hip replacement surgery.","primaryOutcome":{"measure":"Time-weighted Summed Pain Intensity Difference (SPID) Over the 48-hour Study Period (SPID48).","timeFrame":"48 hours","effectByArm":[{"arm":"Sufentanil NanoTab PCA System/15 mcg","deltaMin":76.24,"sd":7.02},{"arm":"Placebo Sufentanil NanoTab PCA System","deltaMin":-11.35,"sd":10.55}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["26079801"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":315},"commonTop":["Nausea","Vomiting","Oxygen Saturation Decreased","Headache","Dizziness"]}}